Portfolio
Full professor
Ivana Munitić
MD, PhD
Faculty of Biotechnology and Drug Development
Contact
T 385 51 584 579
ROOM Odjel za Biotehnologiju, Sveučilište u Rijeci, Radmile Matejčić, O-212
ROOM O-236-laboratorij, telefon: 385 51 584 582
Visibility
Research
Journal Articles
2023.
Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders.
De Marchi, F, Munitic, I, Vidatic, L, Papić, E, Rački, V, Nimac, J, Jurak, I, Novotni, G, Rogelj, B, Vuletic, V, Liscic, RM, Cannon, JR, Buratti, E, Mazzini, L, Hecimovic, S
Biomedicines - 11 2793
https://www.mdpi.com/2227-9059/11/10/2793
Q1
2023.
RNA Editing-Dependent and -Independent Roles of Adenosine Deaminases Acting on RNA Proteins in Herpesvirus Infection-Hints on Another Layer of Complexity
Ivanišević, V, Žilić, L, Čunko, M, Fadiga, H, Munitić, I, Jurak, I
Viruses - 15 2007
https://pubmed.ncbi.nlm.nih.gov/37896783/
Q1
2023.
Neuroimmune characterization of optineurin insufficiency mouse model during ageing.
Mohovic, N, Peradinovic, J, Markovinovic, A, Cimbro, R, Minic, Z, Dominovic, M, Jakovac, H, Nimac, J, Rogelj, B, Munitic, I
Scientific Reports - 13 11840
https://www.nature.com/articles/s41598-023-38875-3
Q1
2023.
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder.
De Marchi, F, Franjkic, T, Schito, P, Russo, T, Nimac, J, Chami, AA, Mele, A, Vidatic, L, Kriz, J, Julien, JP, Apic, G, Russell, RB, Rogelj, B, Cannon, JR, Baralle, M, Agosta, F, Hecimovic, S, Mazzini, L, Buratti, E, Munitic, I
Biomedicines - 11 1599
https://www.mdpi.com/2227-9059/11/6/1599
Q1
2023.
Ageing-Induced Decline in Primary Myeloid Cell Phagocytosis Is Unaffected by Optineurin Insufficiency
Peradinovic J, Mohovic N, Bulic, K, Markovinovic A, Cimbro R, Munitic I
Biology - 12 240
https://www.mdpi.com/2079-7737/12/2/240
Q2
2022.
Optineurin Deficiency and Insufficiency Lead to Higher Microglial TDP-43 Protein Levels
Prtenjaca, N Rob, M Alam, MS Markovinovic, A Stuani, C Buratti, E Munitic, I
International Journal of Molecular Sciences - 23 6829
https://www.mdpi.com/1422-0067/23/12/6829
Q1
2021.
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact
De Marchi, Fabiola ; Munitic, Ivana ; Amedei, Amedeo ; Berry, James D. ; Feldman, Eva L. ; Aronica, Eleonora ; Nardo, Giovanni ; Van Weehaeghe, Donatienne ; Niccolai, Elena ; Prtenjaca, Nikolina ; Sakowski, Stacey A. ; Bendotti, Caterina ; Mazzini, Letizia
Neuroscience & Biobehavioral Reviews - 127 958-978
https://pubmed.ncbi.nlm.nih.gov/34153344/
Q1
2020.
Optineurin dysfunction in amyotrophic lateral sclerosis: why so puzzling?
NIKOLINA PRTENJAČA, MARIN DOMINOVIĆ, JOSIP PERADINOVIĆ, ROZALIJA ŠAJN, ANDREA MARKOVINOVIĆ, IVANA MUNITIĆ
Periodicum Biologorum - 121–122 23–34
https://hrcak.srce.hr/ojs/index.php/periodicum_biologorum/article/view/10627
Q3
2020.
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses
Louis-Charles Béland, Andrea Markovinovic, Hrvoje Jakovac, Fabiola De Marchi, Ervina Bilic, Letizia Mazzini, Jasna Kriz, and Ivana Munitic
Brain Communications - 2 fcaa124
https://academic.oup.com/braincomms/article/2/2/fcaa124/5892251?login=true
Q1
11.12.2019.
Editorial: The Role of Optineurin in Immunity and Immune-Mediated Diseases.
Smith AM, Buss F, Munitic, I.
Frontiers in Immunology - 10 2803
Q1
03.06.2019.
Attenuation of ALS progression during pregnancy-lessons to be learned or just a coincidence
Hancevic, M Bilic, H Sitas, B Pavlisa, G Borovecki, F Munitic, I Bilic, E
Neurological Sciences - 40 1275-1278.
https://www.ncbi.nlm.nih.gov/pubmed/30746559
Q2
20.05.2019.
Glia in ALS and spinal cord injury: common therapeutic targets
Ban, Jelena; Mladinic, Miranda; Sámano, Cynthia; Munitic, Ivana
Croatian medical journal - 60 109-120
https://www.ncbi.nlm.nih.gov/pubmed/31044582
Q2
12.07.2018.
Optineurin Insufficiency Disbalances Proinflammatory and Anti-inflammatory Factors by Reducing Microglial IFN-ß Responses.
Markovinovic A, Ljutic T, Béland LC, and Munitic I.
Neuroscience - 388 139-151
Q1
2017.
Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms
Markovinović, Andrea ; Cimbro, Raffaello ; Ljutić, Tereza ; Križ, Jasna ; Rogelj, Boris ; Munitić, Ivana
Progress in neurobiology - 154 1-20
06.04.2017.
Porphyrin-based cationic amphiphilic photosensitisers as potential anticancer, antimicrobial and immunosuppressive agents.
Malatesti, N Munitic, I Jurak, I
Biophysical Reviews - 9 149-168
2017.
Porphyrin-based cationic amphiphilic photosensitisers as potential anticancer, antimicrobial and immunosuppressive agents
Malatesti, Nela ; Munitic, Ivana ; Jurak, Igor
Biophysical Reviews - 9 149-168
01.09.2016.
Golgi apparatus acts as a platform for TBK1 activation after viral RNA sensing.
Pourcelot M, Zemirli N, Silva Da Costa L, Loyant R, Garcin D, Vitour D, Munitic I, Vazquez A, and Arnoult, D.
BMC Biology - 14 69
https://bmcbiol.biomedcentral.com/articles/10.1186/s12915-016-0292-z
Q1
2016.
The TBK1-binding domain of optineurin promotes type I interferon responses
Meena, Netra Pal ; Zhu, Guozhi ; Mittelstadt, Paul R. ; Giardino Torchia, Maria Letizia ; Pourcelot, Marie ; Arnoult, Damien ; Ashwell, Jonathan D. ; Munitić, Ivana
FEBS letters - 590 1498-1508
2015.
Suppression of Dendritic Cell-Derived IL-12 by Endogenous Glucocorticoids Is Protective in LPS-Induced Sepsis
Li, Caiyi C. ; Munitić, Ivana ; Mittelstadt, Paul R. ; Castro, Ehydel ; Ashwell, Jonathan D.
PLoS biology - 13 1-16
http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002269
2015.
c-IAP ubiquitin protein ligase activity is required for 4-1BB signaling and CD8+ memory T-cell survival
MLG Torchia, I Munitic, E Castro, J Herz, DB McGavern, JD Ashwell
European Journal of Immunology
Q1
2012.
CD70 Deficiency Impairs Effector CD8 T Cell Generation and Viral Clearance but Is Dispensable for the Recall Response to Lymphocytic Choriomeningitis Virus
Munitić, Ivana ; Kuka, M. ; Allam, A. ; Scoville, J. P. ; Ashwell, J.D.
Journal of immunology - 190 1169-1179
http://www.jimmunol.org/content/190/3/1169.abstract?sid=986a0595-f024-496b-a83d-c65be95581da
2013.
CD70 Is Downregulated by Interaction with CD27
Kuka, M. ; Munitić, Ivana ; Giardino Torchia, M.L. ; Ashwell, J.D.
Journal of immunology - 191 2282-2289
http://www.jimmunol.org/content/191/5/2282.abstract?sid=986a0595-f024-496b-a83d-c65be95581da
2013.
Optineurin Insufficiency Impairs IRF3 but not NF-?B Activation in Immune Cells.
Munitic, I*, Giardino Torchia, ML, Meena NP, Zhu G, Li CC, Ashwell, JD*. * Corresponding authors.
The Journal of Immunology, 1301696 (Epub Nov 15)
http://www.jimmunol.org/content/early/2013/11/15/jimmunol.1301696.abstract
Q1
2012.
Identi?cation and characterization of polyclonal ?ß-T cells with dendritic cell properties.
Kuka, M, Munitic, I, Ashwell, JD.
Nature Communications. - 1223
http://www.ncbi.nlm.nih.gov/pubmed/23187623
Q1
2010.
Gamma(c) deficiency precludes CD8+ T cell memory despite formation of potent T cell effectors.
Decaluwe, H. ; Taillardet, M. ; Corcuff, E. ; Munitić, Ivana ; Law, H. K. W. ; Rocha, B. ; Riviere, Y. ; Di Santo, J.P.
Proceedings of the National Academy of Sciences of the United States of America - 107 9311-9316
2010.
Transcriptional Regulation during CD8 T-Cell Immune Responses
Munitic, Ivana ; Evaristo, César ; Sung, Hsueh Cheng ; Rocha, Benedita
Advances in Experimental Medicine and Biology - 11-27
2009.
The CD8+ memory T-cell state of readiness is actively maintained and reversible
Allam, A. ; Conze, D.B. ; Giardino Torchia, M.L. ; Munitić, Ivana ; Yagita, H. ; Sowell, R. T. ; Marzo, A.L. ; Ashwell, J.D.
Blood - 114 2121-2130
2009.
Epitope Specificity and Relative Clonal Abundance Do Not Affect CD8 Differentiation Patterns during Lymphocytic Choriomeningitis Virus Infection
Munitić, Ivana ; Decaluwe, H. ; Evaristo, C. ; Lemos, S. ; Wlodarczyk, M. ; Worth, A. ; Le Bon, A. ; Selin, L.K. ; Riviere, Y. ; Di Santo, J.P. ; Borrow, P. ; Rocha, B.
Journal of virology - 83 11795-11807
2007.
CD8 single-cell gene co-expression reveals three different effector types present at distinct phases of the immune response.
Peixoto A, Evaristo C, Munitic I, Monteiro M, Charbit A, Rocha B. Veiga-Fernandes H.
Journal Experimental Medicine - 204 1193-205.
http://www.ncbi.nlm.nih.gov/pubmed/17485515
Q1
2005.
T Cells in G1 Provide a Memory-Like Response to Secondary Stimulation
Munitić, Ivana ; Ryan, P.E. ; Ashwell, J.D.
Journal of immunology - 174 4010-4018
2004.
Dynamic regulation of IL-7 receptor expression is required for normal thymopoiesis
Munitić, Ivana ; Williams, J.A. ; Yang, Y. ; Dong, B. ; Lucas, P.J. ; El Kassar, N. ; Gress, R.E. ; Ashwell, J.D.
Blood - 104 4165-4172
2002.
Regulation of constitutive T cell receptor internalization by the ? chain.
Oro U*, Munitic I*, Chacko G, Karpova T, McNally J, Ashwell JD. *These authors contributed equally to this manuscript.
Journal of Immunology - 169 6269-78.
http://www.ncbi.nlm.nih.gov/pubmed/12444133
Q1
2007.
CD8 single-cell gene coexpression reveals three different effector types present at distinct phases of the immune response
Peixoto, António ; Evaristo, César ; Munitić, Ivana ; Monteiro, Marta ; Charbit, Alain ; Rocha, Benedita ; Veiga-Fernandes, Henrique
The Journal of experimental medicine - 204 1193-1205
2002.
Regulation of constitutive TCR internalization by the zeta-chain
D'Oro, U. ; Munitić, Ivana ; Chacko, G. ; Karpova, T. ; McNally, J. ; Ashwell, J.D.
Journal of immunology - 169 6269-6278
2013.
Optineurin Insufficiency Impairs IRF3 but Not NF-kappaB Activation in Immune Cells
Munitić, Ivana ; Giardino Torchia, M.L. ; Meena, N. P. ; Zhu, G. ; Li, C.C. ; Ashwell, J.D.
Journal of immunology - 191 6231-6240
2012.
Identification and characterization of polyclonal αβ-T cells with dendritic cell properties
Kuka, Mirela ; Munitić, Ivana ; Ashwell, Jonathan D.
Nature Communications - 3 11
2015.
c-IAP ubiquitin protein ligase activity is required for 4-1BB signaling and CD8+memory T-cell survival
Giardino Torchia, Maria Letizia ; Munitić, Ivana ; Castro, Ehydel ; Herz, Jasmin ; McGavern, Dorian B. ; Ashwell, Jonathan D.
European journal of immunology - 45 2672-2682
2016.
The Golgi apparatus acts as a platform for TBK1 activation after viral RNA sensing
Pourcelot, Marie ; Zemirli, Naima ; Silva Da Costa, Leandro ; Loyant, Roxane ; Garcin, Dominique ; Vitour, Damien ; Munitić, Ivana ; Vazquez, Aimé ; Arnoult, Damien
Bmc biology - 14 18
2018.
Optineurin Insufficiency Disbalances Proinflammatory and Anti- inflammatory Factors by Reducing Microglial IFN-β Responses
Markovinovic, Andrea ; Ljutic, Tereza ; Béland, Louis-Charles ; Munitic, Ivana
Neuroscience - 388 139-151
2019.
Glia in Amyotrophic Lateral Sclerosis and Spinal Cord Injury: Common Therapeutic Targets
Ban, Jelena ; Mladinic, Miranda ; Sámano, Cynthia ; Munitic, Ivana
Croatian medical journal - 60 109-120
2019.
Učinak piridilporfirina na mitohondrije
Janković, Patrizia
- 69
2019.
Attenuation of ALS progression during pregnancy— lessons to be learned or just a coincidence?
Hančević, Mirea ; Bilić, Hrvoje ; Sitaš, Barbara ; Pavliša, Gordana ; Borovečki, Fran ; Munitić, Ivana ; Bilić, Ervina
Neurological sciences - 40 1275-1278
2019.
Editorial: The Role of Optineurin in Immunity and Immune-Mediated Diseases
Smith, Andrew M. ; Buss, Folma ; Munitic, Ivana
Frontiers in Immunology - 10 3
2020.
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses
Béland, Louis-Charles ; Markovinovic, Andrea ; Jakovac, Hrvoje ; De Marchi, Fabiola ; Bilic, Ervina ; Mazzini, Letizia ; Kriz, Jasna ; Munitic, Ivana
Brain Communications - 2 1-26
2020.
Optineurin Dysfunction in Amyotrophic Lateral Sclerosis: Why So Puzzling?
Prtenjaca, Nikolina ; Dominovic, Marin ; Peradinovic, Josip ; Šajn, Rozalija ; Markovinovic, Andrea ; Munitic, Ivana
Periodicum biologorum - 121-122 23-34
2019.
The project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public
van der Spek, Rick A.A. ; van Rheenen, Wouter ; Pulit, Sara L. ; Kenna, Kevin P. ; van den Berg, Leonard H. ; Veldink, Jan H. ; on behalf of the Project MinE ALS Sequencing Consortium
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration - 20 432-440
Books
2025.
Poglavlje "Upala" u udžbeniku Patofiziologija
koautorica
Ivana Munitić
Upala (poglavlje)
S. Gamulin i M. Marušić
Medicinska naklada Zagreb
2019
Poglavlje "Uloga imunosnog sustava u nastanku i progresiji amiotrofične lateralne skleroze" u priručniku: Dijagnostika i liječenje bolesti motoričkih neurona
autor poglavlja u priručniku
Munitić Ivana i Miholović Vesna
Uloga imunosnog sustava u nastanku i progresiji amiotrofične lateralne skleroze
Ervina Bilić
Medicinska naklada Zagreb
Invited Lectures
2025.
The Present and Future of Targeting Immunity in Neurodegenerative Diseases; Alzheimer's association AAIC Neuroscience next.
Ivana Munitić
Beograd, Srbija (online)
2024.
Immune Imbalance during Aging: Lessons from the Mouse Models, UPO Aging Project, University of Eastern Piedmont.
Ivana Munitić
Novara, Italija.
2024.
Analysis of OPTN variants in neurodegenerative diseases, 8th Rijeka Forum on Neurodegenerative Diseases.
Ivana Munitić
Rijeka, Croatia
2023.
Immune Imbalance during Ageing, SiNAPSA Neuroscience Conference '23,
Ivana Munitić
Ljubljana, Slovenia
2023.
Neuroimmunity in amyotrophic lateral sclerosis – mechanistic potential, 7th Rijeka forum on neurodegenerative diseases, Rijeka, Croatia
Ivana Munitić
Rijeka, Croatia.
2023.
Neuroinflammation: A key target or bye-player in neurodegenerative diseases?; Controversies in Neurology (CONy).
Ivana Munitić
Dubrovnik, Croatia
2023.
Je li ALS upalna bolest?; Dileme u neurologiji.
Ivana Munitić
Brač, Hrvatska
2022.
Multifaceted role of optineurin in neurodegenerative diseases, 6th Rijeka forum on neurodegenerative diseases.
Ivana Munitić
Rijeka, Croatia
2022.
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses, 10th Croatian Congress of Pharmacology.
Ivana Munitić
Opatija, Croatia
2022.
The love-hate relationship between the brain and the immune system, Darwin Regional conference (online) Rijeka, Croatia.
Ivana Munitić
online
27.09.2019.
Optineurin Dysfunction in Amyotrophic Lateral Sclerosis (HDBMB Crossroads in Life Sciences)
Munitic I
Lovran, Croatia.
01.06.2019.
Optineurin Dysfunction in Neurodegeneration (Mind & Brain)
Munitic I
Pula, Croatia.
11.05.2019.
Immunity in Amyotrophic Lateral Sclerosis (International Conference on Neurological Disorders and Neurorestoration)
Munitic I
Dubrovnik, Croatia
05.10.2018.
Imunologija u ALS-u: pogled unatrag i unaprijed; Simpozije Dileme u neurologiji 2018
I. Munitić
Poreč
10.05.2018.
Cijepljenje: znanstvene i etičke dimenzije; Filozofski fakultet Sveučilišta u Rijeci
I. Munitić
Rijeka
03.05.2018.
Neuroimmunology of ALS (4th Croatian Neuroimmunological Congress with international participation)
Munitic I
Opatija, Hrvatska
02.02.2018.
Razvoj novih životinjskih modela za istraživanje amiotrofične lateralne skleroze; Godišnja skupština Hrvatskog društva za znanost o laboratorijskim životinjama (CroLASA),.
I. Munitić
Institut Ruđer Bošković, Zagreb
17.10.2017.
Animal Models of Amyotrophic Lateral Sclerosis; Croatian National Academy of Sciences and Arts 1st Rijeka Forum on Neurodegenerative Diseases, Rijeka,Croatia.
I. Munitić
Rijeka
19.09.2017.
Elucidating the role of optineurin in amyotrophic lateral sclerosis; Laval University, CERVO Brain, Research Centre Quebec City, Canada.
I. Munitić
Quebec City, Canada
16.09.2017.
Characterization of the role of optineurin in neurodegeneration, 13th Symposium of the André-Delambre Foundation, Montreal, Canada.
I. Munitić
Montreal, Canada
12.05.2017.
Molecular characterization of mouse optineurin insufficiency models; Regional meeting of clinicians and basic scientists that work on ALS, Ljubljana, Slovenia.
I. Munitić
Ljubljana
25.04.2017.
Istraživanje uloge optineurina u neuroprotekciji, Rijeka, travanj 2017, Predstavljanje uspostavnog istraživačkog projekta Hrvatske zaklade za znanost (HRZZ).
Ivana Munitić
Medicinski fakultet, Rijeka
04.07.2016.
Symposium: Translation of Basic Immunology and Neuroscience Tools to Therapies: Where are We Now?; Croatian Academy for Sciences and Arts and Department of Biotechnology. Talk title: Animal models for elucidating the role of adaptor protein optineurin during inflammation.
Ivana Munitić
Odjel za biotehnologiju, Rijeka.
2016.
Iskustva i izazovi istraživača u biomedicini
Ivana Munitić
Filozofski fakultet Sveučilišta u Rijeci
14.10.2014.
Tribina HAZU, KBC – HLZ Podružnica Rijeka: "NOVIJA POSTIGNUĆA U IMUNOLOGIJI I HEMATOLOGIJI" Naslov predavanja: Nove funkcije dendritičkih stanica.
Ivana Munitić
Rijeka, Hrvatska.
01.09.2014.
10th Symposium of the André-Delambre Foundation, Amyotrophic Lateral Sclerosis: Causes and Therapeutic Perspectives. Naslov predavanja: A Mouse Model of Optineurin Insufficiency
Ivana Munitić
Montreal, Canada.
Conference Presentations
2017
Characterization of the role of optineurin in neuroinflammation.
Andrea Markovinović, Tereza Ljutić, Milojević i Ivana Munitić
poster
Atypical dementias: from diagnosis to emerging therapies Trst, Italija.
2017
Neurohistopathological characterization of an optineurin insufficiency mouse model.
Hrvoje Jakovac, Andrea Markovinovic and Ivana Munitic
poster
Congress of Croatian Physiological Society and Regional Congress of the Physiological Societies Dubrovnik, Croatia
2017
Characterization of the role of optineurin in neurodegeneration.
Andrea Markovinović, Tereza Ljutić, Milojević i Ivana Munitić
poster
Young Neuroscientists Meeting (YMN) Zagreb, Croatia
2017
Characterization of neurodegeneration in an optineurin insufficiency mouse model.
Hrvoje Jakovac, Andrea Markovinovic and Ivana Munitic
poster
Annual Meeting Of The Croatian Immunological Society With EFIS On Tour Zagreb, Croatia
2017
Molecular characterization of mouse optineurin insufficiency models.
Andrea Markovinović, Tereza Ljutić i Ivana Munitić
poster
European Network for the Cure for ALS (ENCALS) meeting Ljubljana, Slovenija.
2017
Characterization of the optineurin insufficiency mouse model.
Tereza Ljutić, Andrea Markovinović, Sai Sampath Thammisetty, Jasna Križ, Ivana Munitić.
poster
Scientific poster day of CERVO Institute. Quebec city, Canada.
2016
An optineurin insufficiency model of ALS.
Munitic I, Markovinovic A, and Ashwell JD.
usmena prezentacija
ENCALS (European Network for the Cure of ALS) meeting Milano, Italy
2016.
An optineurin insufficiency model of ALS.
Munitic I, Markovinovic A, and Ashwell JD.
odabrano usmeno izlaganje
ENCALS (European Network for the Cure of ALS) meeting. Milano, Italy.
2015.
An optineurin insufficiency model as a potential tool for elucidating the pathogenesis of amyotrophic lateral sclerosis.
Markovinović A, Barukčić A, Jakopović M, Šinkovec V, Jakovac H, Grabušić K, Ashwell JD, and Munitić I.
poster
Croatian Society for Neuroscience meeting. Split, Croatia.
2015.
Endogenous glucocorticoids suppress dendritic cell-derived IL-12 and prevent death in LPS-induced sepsis, Selected Oral presentation.
Munitic I, Li CC, Mittelstadt PR, Castro E, and Ashwell JD.
odabrano usmeno izlaganje
4th European Congress of Immunology. Vienna, Austria.
2015.
Optineurin is dispensable for LPS- and Salmonella typhimurium-induced autophagy.
Munitic I, Giardino Torchia ML, and Ashwell JD.
poster
American Associations of Immunologists Annual Meeting. New Orleans, USA.
2014.
Optineurin is a Positive Regulator of IFN-ß.
Munitic I, Giardino Torchia ML, Meena NP, and Ashwell JD.
odabrano usmeno izlaganje
Annual meeting of the Croatian Imunological Society. Krk, Croatia.
2013.
A Mouse Model of Optineurin Insufficiency Exhibits Impaired Signaling via IRF3 but not NF-?B Activation Pathway.
Munitic I, Giardino Torchia ML, Meena NP, and Ashwell JD.
poster
4th Croatian Neuroscience Congres. Zagreb, Croatia.
2013.
Optineurin is Indispensible for Signaling via IRF3 but not NF-?B Activation Pathway.
Munitic I, Giardino Torchia ML, Meena NP, and Ashwell JD.
poster
2nd Meeting on Middle-European Societies for Immunology and Allergology. Opatija, Croatia.
Mentoring doctoral students
2022. -
Analysis of genetic variants of unknown significance in amyotrophic lateral sclerosis
Toni Franjkić Doctorate
Medicinska kemija
Fakultet biotehnologije i razvoja lijekova
2020. - 2025.
Immune-mediated pathologies in an optineurin insufficiency mouse model
Josip Peradinović Doctorate
Medicinska kemija
Fakultet biotehnologije i razvoja lijekova, Sveučilište u Rijeci
2019. - 2023.
Crosstalk of TDP-43 and optineurin in amiotrophic lateral sclerosis AMYOTROPHIC LATERAL SCLEROSIS MODELS
Nikolina Mohović (rođ. Prtenjača) Doctorate
Medicinska kemija
Odjel za biotehnologiju, Sveučilište u Rijeci
Date of degree: 08.10.2023.
2016. -
Establishing human peripheral blood optineurin deficiency models and evaluating their inflammatory profiles as a potential disease biomarkers
Raffaello Cimbro Doctorate
Medicinska kemija
Fakultet biotehnologije i razvoja lijekova
2015. - 2018.
Evaluacija neuroinflamacije u mišjem modelu insuficijencije optineurina
Andrea Markovinović Doctorate
Medicinska kemija
Odjel za biotehnologiju, Sveučilište u Rijeci
Date of degree: 12.2018.
Organisation of Conferences and Symposia
07.05.2018. - 07.05.2018.
2nd Meeting Of Basic Researchers And Clinicians Working On ALS (SLO/HR)
Odjel za biotehnologiju, Rijeka organizator
30.06.2016. -
International symposium for young neuroscience researchers: 20th Young Neuroscientists Meeting.
Odjel za biotehnologiju, Rijeka, Croatia. ko-organizator (glavni organizator Miranda Mladinić Pejatović)
4-5 srpnja 2016
Simpozij u organizaciji HAZU i Odjela za biotehnologiju (iz projekta voditeljice projekta, I. Munitić): TRANSLATION OF BASIC IMMUNOLOGY AND NEUROSCIENCE TOOLS TO THERAPIES:Where Are We Now?
Rijeka suorganizator (član znanstvenog odbora i predsjednik organizacijskog odbora)
Journal Editor
2023. - 2025.
Gostujući urednik za specijalno izdanje International Journal of Molecular Sciences: Immunity in Neurodegenerative Diseases: Systemic Immune Imbalance, Neuroinflammation, and Beyond
https://www.mdpi.com/journal/ijms/special_issues/Immunity_Neurodegenerative_Diseases#keywords
2017-2018
Gostujući urednik za časopis Frontiers in Immunology; tema: The Role of Optineurin in Immunity and Immune-Mediated Diseases.
Peer Reviews
2017
Recenzent programa cjeloživotnog učenja (Sveučilište u Rijeci)
2016-2018
HRZZ recenzent
Projects
Research Projects
16.12.2024. - 15.12.2027.
Translational platform for improved pathogenicity prediction of OPTN variants in amyotrophic lateral sclerosis and related neurodegenerative diseases
voditeljica
HRZZ HRZZ
01.10.2018. - 30.09.2022.
Controlling neurodegeneration by modulating the crosstalk between inflammation and proteinopathy
voditeljica
HRZZ 1.000.000, 00 kn
2014. - 2017.
Elucidating the Role of Optineurin in Neuroprotection.
voditeljica
HRZZ 1,000,000 kn